Fujitsu Expands Mid-career Recruitment

Nov 11, 2019 10:33 JST

Source: Fujitsu Ltd

TOKYO, Nov 11, 2019 - (JCN Newswire) - Fujitsu Limited today announced that it will increase the number of mid-career recruitment from the previously planned 150 to 300 in fiscal 2019. The company aims to further strengthen its talent in order to expand the DX Business as stated in its management policy.

In expanding the number of new hires, Fujitsu will accelerate the recruitment of highly specialized talent, such as AI engineers, cybersecurity engineers and data scientists, expected to comprise a competent, business-ready workforce. In addition, the company will newly recruit talent with few to several years of work experience in another company where they joined as new graduates. Fujitsu will seek their potential for future growth regardless of their IT related work experience, in order to recruit diverse and highly-skilled talent from both within and outside Japan.

In line with the expansion of career recruitment, Fujitsu will also create a training environment in which each employee can select necessary training, ensuring that new hires can develop their career at an early stage. In addition, Fujitsu will support the growth of mid-career talent by offering training to help them acquire the same level of IT-related business knowledge as new graduates.

Fujitsu is working to strengthen its human resources by increasing the number of career hires and by hiring new graduates throughout the year starting in fiscal 2019. By accelerating the shift from IT companies to DX companies, we are contributing to solving various issues facing customers and society.

Contact:

Fujitsu Limited
Public and Investor Relations
Tel: +81-3-3215-5259
URL: www.fujitsu.com/global/news/contacts/

Source: Fujitsu Ltd
Sectors: Electronics, Enterprise IT

Related Press Release

Fujitsu to showcase mobility and physical AI tech at CES 2026

December 19 2025 01:42 JST

Kirin and Fujitsu elucidate a novel gut-brain axis mechanism of citicoline for the first time worldwide through AI-based analysis and experimental validation leveraging drug discovery DX technology

December 19 2025 01:06 JST

Fujitsu and Scaleway partner to accelerate European sustainable transformation and data sovereignty with FUJITSU-MONAKA CPU-based AI inference

December 04 2025 18:08 JST

Fujitsu develops new technology to support human-robot collaboration

December 02 2025 22:26 JST

Fujitsu establishes international consortium to tackle disinformation/misinformation and new AI risks

December 02 2025 21:55 JST

Fujitsu achieves high-precision, long-duration molecular dynamics simulation for all-solid-state battery interphases with over 100,000 atoms

December 01 2025 22:04 JST

Fujitsu develops multi-AI agent collaboration technology to optimize supply chains, launches joint trials

December 01 2025 21:43 JST

Fujitsu launches 'Fujitsu Accelerator Program for SPORTS' to create new value through Sports x Technology

December 01 2025 21:14 JST

Fujitsu builds platform for NSK to create environmental value throughout the product lifecycle of bearing products

November 28 2025 17:01 JST

Fujitsu launches Japan Edition of SAP Fioneer Cloud for Insurance, a next-generation platform supporting core business operations in the Japanese insurance industry

November 28 2025 16:28 JST

More Press release >>

Latest Press Release

MHI Participates in Demonstration Testing of Vehicle-Infrastructure Integration System for Autonomous Buses in Shimotsuke City
Dec 19, 2025 03:24 JST

NEC and emaratech Collaborate on Biometric Smart Gates Supporting UAE Airport Operations
Dec 19, 2025 03:06 JST

Fujitsu to showcase mobility and physical AI tech at CES 2026
Dec 19, 2025 02:42 JST

Kirin and Fujitsu elucidate a novel gut-brain axis mechanism of citicoline for the first time worldwide through AI-based analysis and experimental validation leveraging drug discovery DX technology
Dec 19, 2025 02:06 JST

TANAKA PRECIOUS METAL GROUP and TANAKA MIRAI Lab. Released Their Fourth Collaborative Musical Work with Sound Wellness Lab (Della): "Precious Metal Orchestra - A Musical Voyage through the Sound of Precious Metals for Christmas" now available for streaming.
Dec 18, 2025 22:00 JST

PropertyGuru Asia Real Estate Summit spotlights PropertyGuru Week 2025 with conversations on 'Trusted Marketplaces and Thriving Communities'
Dec 18, 2025 10:00 JST

SAKENOVA: 28-Year-Old Master Brewer Pioneers AI-Driven Sake Revolution, Achieving 40% Cost Reduction While Winning International Gold Medals
Dec 15, 2025 23:00 JST

NEC Provides Vehicle Management Equipment for Autonomous Driving at Tokyo International Airport
Dec 15, 2025 19:41 JST

NEC and AEROTHAI Elevate Air Traffic Safety with Advanced Time Sync Solutions from Adtran Oscilloquartz
Dec 15, 2025 19:04 JST

Olympus Triples Venture Capital Fund Investment to Strengthen MedTech Leadership
Dec 15, 2025 08:30 JST

HKTDC 4Q25 Export Confidence Index: 2026 Hong Kong Export Growth of 8-9%, Sustained AI product demand lays solid foundation for future expansion
Dec 12, 2025 23:15 JST

Honda to Launch New Heritage Service Business

Dec 12, 2025 20:31 JST

Bank Mandiri Enhances Digital Resiliency for Financial Trading in Indonesia through Advanced Time Sync Solutions with NEC and Adtran Oscilloquartz
Dec 12, 2025 19:59 JST

NEC and ClimateAi sign a Memorandum of Understanding (MoU) for business co-creation to enhance climate resilience across various industries
Dec 12, 2025 18:13 JST

Anime Tokyo Station: A Series of Linked Events to Be Held in Conjunction with the Anniversary Joint Exhibition
Dec 12, 2025 11:00 JST

Eisai Rated "A", the Highest Rating by CDP in Both Climate Change and Water Security Categories for the Second Consecutive Year
Dec 11, 2025 19:41 JST

NEC Named to CDP's "A List" for Climate Change and Water Security for the Seventh Consecutive Year
Dec 11, 2025 19:00 JST

MHI Successfully Produces Hydrogen at Its Ammonia Cracking Pilot Plant Using Steam Heating
Dec 10, 2025 18:14 JST

NEC Presents Phase I Results for Personalized AI-Powered Oral Cancer Vaccine NECVAX-NEO1 at ESMO Immuno-Oncology Congress 2025
Dec 10, 2025 12:00 JST

"LEQEMBI(R)" (lecanemab) for the Treatment of Early Alzheimer's Disease Included in China's Commercial Insurance Innovative Drug List
Dec 09, 2025 18:51 JST

More Latest Release >>